JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

DHR

174.62

+0.32%↑

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

DHR

174.62

+0.32%↑

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

DHR

174.62

+0.32%↑

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

DHR

174.62

+0.32%↑

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

DHR

174.62

+0.32%↑

Search

Abbott Laboratories

Uždarymo kaina

SektoriusSveikatos priežiūra

87.15 -0.47

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

86.15

Max

87.81

Pagrindiniai rodikliai

By Trading Economics

Pajamos

132M

1.8B

Pardavimai

-295M

11B

P/E

Sektoriaus vid.

25.994

67.147

Pelnas, tenkantis vienai akcijai

1.15

Dividendų pajamingumas

2.68

Pelno marža

15.499

Darbuotojai

122,000

EBITDA

-980M

1.8B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+37.35% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

2.68%

2.36%

Kitas uždarbis

2026-07-16

Kitas dividendų mokėjimo data

2026-05-15

Kita Ex Dividend data

2026-07-14

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-14B

161B

Ankstesnė atidarymo kaina

87.62

Ankstesnė uždarymo kaina

87.15

Naujienos nuotaikos

By Acuity

24%

76%

85 / 347 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

Abbott Laboratories Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-16 15:13; UTC

Uždarbis
Pagrindinės rinkos jėgos

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt 1Q Sales -- Update

2026-04-16 12:23; UTC

Uždarbis
Pagrindinės rinkos jėgos

Abbott Laboratories Cuts Outlook, Narrows 1Q Profit

2026-01-22 18:36; UTC

Uždarbis
Pagrindinės rinkos jėgos

Abbott Laboratories Raised Prices, Prompting Sales Slump -- Update

2026-01-22 13:23; UTC

Uždarbis
Pagrindinės rinkos jėgos

Abbott Laboratories 4Q Sales Grow, Outlook Underwhelms

2026-04-16 20:23; UTC

Uždarbis

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

2026-04-16 16:15; UTC

Uždarbis

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

2026-04-16 14:00; UTC

Rinkos pokalbiai
Uždarbis

A Mild Flu Season Hurt Abbott's Recent Quarter -- Market Talk

2026-04-16 13:59; UTC

Rinkos pokalbiai
Uždarbis

Abbott Laboratories Has Disappointing Quarter -- Market Talk

2026-04-16 12:05; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. -- Barrons.com

2026-04-16 11:32; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Abbott Labs: 2026 EPS View Includes 20c Dilution Related to Exact Sciences Buy >ABT

2026-04-16 11:30; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Abbott Labs Sees 2Q Adj EPS $1.25-Adj EPS $1.31 >ABT

2026-04-16 11:30; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Abbott Labs Sees 2026 Comparable Sales Growth of 6.5%-7.5% >ABT

2026-04-16 11:30; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Abbott Labs Updates Guidance to Reflect Acquisition of Exact Sciences >ABT

2026-04-16 11:30; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Abbott Labs 1Q Sales $11.16B >ABT

2026-04-16 11:30; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Abbott Reports First-Quarter 2026 Results; Updates Guidance To Reflect Acquisition Of Exact Sciences >ABT

2026-04-16 11:30; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Abbott Labs 1Q Net $1.08B >ABT

2026-04-16 11:30; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Abbott Labs 1Q Adj EPS $1.15 >ABT

2026-04-16 11:30; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Abbott Labs Sees FY Adj EPS $5.38-Adj EPS $5.58 >ABT

2026-04-16 11:30; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Abbott Labs 1Q EPS 61c >ABT

2026-04-11 00:00; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Big Yachts, Big Bucks -- Barrons.com

2026-03-23 12:50; UTC

Įsigijimai, susijungimai, perėmimai

Abbott Completes Acquisition Of Exact Sciences >ABT

2026-03-20 13:01; UTC

Įsigijimai, susijungimai, perėmimai

Abbott Labs: Received All Regulatory Clearances for Exact Sciences Buy >ABT EXAS

2026-03-20 13:00; UTC

Įsigijimai, susijungimai, perėmimai

Abbott Acquisition Of Exact Sciences Set To Close On March 23, 2026 >ABT

2026-01-28 14:48; UTC

Uždarbis

Abbott Stock Fell the Most in 23 Years After Earnings. The CEO Bought $2 Million of Shares. -- Barrons.com

2026-01-23 16:59; UTC

Uždarbis

Correction to Abbott Stock Drops Article on Jan. 22

2026-01-22 20:42; UTC

Uždarbis

Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

2026-01-22 16:19; UTC

Uždarbis

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

2026-01-22 15:22; UTC

Uždarbis

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes -- WSJ

2026-01-22 14:41; UTC

Karštos akcijos

Stocks to Watch Thursday: Intel, P&G, GE Aerospace -- WSJ

2026-01-22 14:08; UTC

Rinkos pokalbiai
Uždarbis

Abbott Posts Disappointing 4Q -- Market Talk

Akcijų palyginimas

Kainos pokytis

Abbott Laboratories Prognozė

Kainos tikslas

By TipRanks

37.35% į viršų

12 mėnesių prognozė

Vidutinis 120.24 USD  37.35%

Aukščiausias 143 USD

Žemiausias 92 USD

Remiantis 20 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Abbott Laboratories kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

20 ratings

16

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

132.82 / 134.43Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bullish Evidence

Vidutinės trukmės periodas

Neutral Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

85 / 347 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat